Midterm Safety and Efficacy of ABSORB Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent: An Updated Meta-Analysis.
Francis J
FJ
Ha
Nitesh
N
Nerlekar
James D
JD
Cameron
Martin R
MR
Bennett
Ian T
IT
Meredith
Nick E J
NE
West
Adam J
AJ
Brown
D020341:Absorbable Implants; D002317:Cardiovascular Agents / Q000008:administration & dosage* / Q000009:adverse effects; D054855:Drug-Eluting Stents; D000068338:Everolimus / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008670:Metals; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D064887:Observational Studies as Topic; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality; D011474:Prosthesis Design; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D002317:Cardiovascular Agents; D008670:Metals; D000068338:Everolimus